Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) EPS (Basic) (2016 - 2025)

Jaguar Health (JAGX) has disclosed EPS (Basic) for 11 consecutive years, with -$6.28 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 95.61% to -$6.28 in Q3 2025 year-over-year; TTM through Sep 2025 was -$13.21, a 99.52% increase, with the full-year FY2024 number at -$130.69, up 95.12% from a year prior.
  • EPS (Basic) was -$6.28 for Q3 2025 at Jaguar Health, up from -$10.26 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $20.03 in Q4 2024 to a low of -$2545.7 in Q4 2023.
  • A 5-year average of -$160.15 and a median of -$6.41 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): tumbled 578663.64% in 2023, then surged 100.79% in 2024.
  • Jaguar Health's EPS (Basic) stood at -$87.57 in 2021, then soared by 100.5% to $0.44 in 2022, then plummeted by 578663.64% to -$2545.7 in 2023, then soared by 100.79% to $20.03 in 2024, then tumbled by 131.35% to -$6.28 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's EPS (Basic) are -$6.28 (Q3 2025), -$10.26 (Q2 2025), and -$16.7 (Q1 2025).